Our studies show that the cardiac glycoside and specific inhibitor of Na,K-ATPase, ouabain, can inhibit EGF-induced signaling and cell migration in medulloblastoma cells, but not glioblastoma cells, and indeed support the notion of developing novel therapeutic approaches targeting the sodium pump. Here, ATP12A is linked to medulloblastoma.